Free Trial

B. Metzler seel. Sohn & Co. Holding AG Buys Shares of 23,674 The Cigna Group (NYSE:CI)

The Cigna Group logo with Medical background

B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of The Cigna Group (NYSE:CI - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 23,674 shares of the health services provider's stock, valued at approximately $8,202,000.

Other institutional investors also recently made changes to their positions in the company. Van ECK Associates Corp boosted its position in The Cigna Group by 4.4% during the second quarter. Van ECK Associates Corp now owns 14,872 shares of the health services provider's stock valued at $4,916,000 after acquiring an additional 625 shares during the last quarter. Marks Group Wealth Management Inc raised its holdings in shares of The Cigna Group by 3,669.7% in the 3rd quarter. Marks Group Wealth Management Inc now owns 24,013 shares of the health services provider's stock worth $8,319,000 after acquiring an additional 23,376 shares during the last quarter. Hancock Whitney Corp raised its holdings in shares of The Cigna Group by 75.6% in the 1st quarter. Hancock Whitney Corp now owns 3,783 shares of the health services provider's stock worth $1,374,000 after acquiring an additional 1,629 shares during the last quarter. ORG Partners LLC acquired a new stake in shares of The Cigna Group in the 2nd quarter worth about $489,000. Finally, Tidal Investments LLC increased its stake in The Cigna Group by 36.0% in the 1st quarter. Tidal Investments LLC now owns 15,276 shares of the health services provider's stock valued at $5,548,000 after buying an additional 4,043 shares during the last quarter. Institutional investors own 86.99% of the company's stock.

The Cigna Group Stock Performance

Shares of CI traded up $0.86 during mid-day trading on Wednesday, reaching $323.36. The company's stock had a trading volume of 1,527,310 shares, compared to its average volume of 1,542,903. The stock has a market cap of $89.94 billion, a P/E ratio of 30.51, a PEG ratio of 0.97 and a beta of 0.51. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $370.83. The business has a 50-day simple moving average of $336.78 and a two-hundred day simple moving average of $339.03.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping the consensus estimate of $7.22 by $0.29. The firm had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business's quarterly revenue was up 29.8% on a year-over-year basis. During the same period last year, the company posted $6.77 EPS. As a group, equities research analysts anticipate that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be given a dividend of $1.40 per share. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 annualized dividend and a yield of 1.73%. The Cigna Group's payout ratio is 52.83%.

Wall Street Analyst Weigh In

Several research analysts recently commented on CI shares. Stephens reaffirmed an "overweight" rating and issued a $410.00 price objective on shares of The Cigna Group in a report on Friday, November 1st. Piper Sandler reiterated an "overweight" rating and issued a $394.00 target price (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. JPMorgan Chase & Co. upped their price objective on shares of The Cigna Group from $435.00 to $438.00 and gave the company an "overweight" rating in a research note on Wednesday, August 21st. StockNews.com cut shares of The Cigna Group from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and issued a $400.00 price target on shares of The Cigna Group in a research report on Wednesday, October 23rd. One research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $394.64.

Read Our Latest Stock Analysis on CI

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

→ This company will win the AI race (From Porter & Company) (Ad)

Should you invest $1,000 in The Cigna Group right now?

Before you consider The Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.

While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines